Back to Archived Journals » Core Evidence » Volume 6

Emerging role of carfilzomib in treatment of relapsed and refractory lymphoid neoplasms and multiple myeloma

Total article views   HTML views PDF downloads Totals
15,897 Dovepress* 10,954+ 4,701 15,655
PubMed Central* 4,943 1,425 6,368
Totals 15,897 6,126 22,023
*Since 4 April 2011
+Since July 2016
Total mentioned Facebook Delicious Reddit Twitter Others
5 0 0 0 1 4

View citations on PubMed Central and Google Scholar